Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

被引:4
作者
Li, Dunhui [1 ,2 ,3 ]
Mastaglia, Frank L. [1 ,2 ]
Yau, Wai Yan [1 ]
Chen, Shengdi [4 ,5 ]
Wilton, Steve D. [1 ,2 ]
Akkari, Patrick A. [1 ,2 ,6 ]
机构
[1] Univ Western Australia, Perron Inst Neurol & Translat Sci, 8 Verdun St, Nedlands, WA 6009, Australia
[2] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia
[3] Zhengzhou Univ, Coll Nursing & Hlth, Zhengzhou, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Inst Neurol, Sch Med, Shanghai, Peoples R China
[6] Duke Univ, Dept Neurol, Durham, NC USA
基金
中国国家自然科学基金;
关键词
D O I
10.1002/mds.29201
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:2184 / 2190
页数:7
相关论文
共 50 条
[21]   miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease [J].
Suvarna, Vasanti ;
Deshmukh, Kajal ;
Murahari, Manikanta .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[22]   RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System [J].
Ertural, Betul ;
Cicek, Busra Nur ;
Kurnaz, Isil Aksan .
BIOMOLECULES & THERAPEUTICS, 2025, 33 (04) :572-581
[23]   RNA therapeutics: beyond RNA interference and antisense oligonucleotides [J].
Ryszard Kole ;
Adrian R. Krainer ;
Sidney Altman .
Nature Reviews Drug Discovery, 2012, 11 :125-140
[24]   Antisense Oligonucleotides As Potential Therapeutics for Type 2 Diabetes [J].
Chen, Suxiang ;
Sbuh, Nabayet ;
Veedu, Rakesh N. .
NUCLEIC ACID THERAPEUTICS, 2021, 31 (01) :39-57
[25]   Selective Suppression of α-Synuclein in Monoaminergic Neurons of Mice by Intranasal Delivery of Targeted Small Interfering RNA or Antisense Oligonucleotides: Potential Therapy for Parkinson's Disease [J].
Recasens, Ariadna ;
Galofre, Mireia ;
Carballo-Carbajal, Iria ;
Ferres-Coy, A. ;
Bove, Jordi ;
Perier, Celine ;
del Carmen Carmona, Maria ;
Santos, M. I. ;
Baena, S. ;
Rosario Chica, M. ;
Montefeltro, Andres P. ;
Revilla, R. ;
Bortolozzi, Analia .
NEUROPSYCHOPHARMACOLOGY, 2013, 38 :S419-S420
[26]   Experimental therapeutics of Parkinson's disease [J].
Henderson, JM .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (11) :841-844
[27]   Botanical Therapeutics for Parkinson's Disease [J].
LI Wen-wei .
Chinese Journal of Integrative Medicine, 2020, 26 (06) :405-411
[28]   Botanical Therapeutics for Parkinson’s Disease [J].
Wen-wei Li .
Chinese Journal of Integrative Medicine, 2020, 26 :405-411
[29]   Therapeutics in the neurorehabilitation of Parkinson's disease [J].
Colcher, A ;
Stern, MB .
NEUROREHABILITATION AND NEURAL REPAIR, 1999, 13 (04) :205-218
[30]   Botanical Therapeutics for Parkinson's Disease [J].
Li, Wen-wei .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (06) :405-411